Clinical trial
The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG)
NCT07200518 is registered in ClinicalTrials.gov with University Maribor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG)
- Lead sponsor
- University Maribor
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 3, 2025
- Completion date
- June 1, 2027
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healing